Try

Pacific Biosciences of California Inc. Common Stock

PACBUnited States

5 filed reports · 299 financial concepts · 4 earnings calls · 0 media appearances

Filed reports

5 reports · Jun 2025 to Jun 2026

Each report counts once it has at least one extracted financial fact.

Report typeReportsFactsPeriods
Quarterly · 10-QSEC EDGAR41,008Jun 2025 to Jun 2026
Annual · 10-KSEC EDGAR1894Dec 2025

Documents

PeriodTypePeriod endPublishedFactsSource
FY2026 Q210-QJun 30, 2026Aug 6, 2026378Open
FY2026 Q110-QMar 31, 2026May 8, 2026252Open
FY202510-KDec 31, 2025Feb 25, 2026894Open
FY2025 Q310-QSep 30, 2025Nov 6, 2025255Open
FY2025 Q210-QJun 30, 2025Aug 7, 2025123Open

Financial data

299 concepts · 1,902 facts

Each concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.

Financial279 concepts · 1,638 facts · Jan 2023 to Jun 2026

  • Cash and cash equivalents at carrying value13 · Dec 2023 to Jun 2026
  • Cash cash equivalents restricted cash and restricted cash equivalents13 · Dec 2023 to Jun 2026
  • Product warranty accrual13 · Dec 2023 to Jun 2026
  • Restricted cash and cash equivalents13 · Dec 2023 to Jun 2026
  • Stockholders equity (US GAAP)13 · Dec 2023 to Jun 2026
  • Adjustments to additional paid in capital sharebased compensation requisite service period recognition value12 · Dec 2023 to Jun 2026
  • Amortization of acquired intangible assets12 · Dec 2023 to Jun 2026
  • Comprehensive income net of tax12 · Dec 2023 to Jun 2026
  • Cost of goods and services sold amortization12 · Dec 2023 to Jun 2026
  • Cost of revenue (US GAAP)12 · Dec 2023 to Jun 2026
  • Goodwill and intangible asset impairment12 · Dec 2023 to Jun 2026
  • Gross profit (US GAAP)12 · Dec 2023 to Jun 2026
  • Income tax expense benefit12 · Dec 2023 to Jun 2026
  • Interest expense nonoperating12 · Dec 2023 to Jun 2026
  • Loss on purchase commitment12 · Dec 2023 to Jun 2026
  • Net income loss12 · Dec 2023 to Jun 2026
  • Net income loss available to common stockholders basic12 · Dec 2023 to Jun 2026
  • Operating expenses (US GAAP)12 · Dec 2023 to Jun 2026
  • Operating income loss12 · Dec 2023 to Jun 2026
  • Other comprehensive income availableforsale securities adjustment net of tax portion attributable to parent12 · Dec 2023 to Jun 2026
  • Other comprehensive income loss net of tax portion attributable to parent12 · Dec 2023 to Jun 2026
  • Other nonoperating income expense12 · Dec 2023 to Jun 2026
  • Research and development expense12 · Dec 2023 to Jun 2026
  • Revenue12 · Dec 2023 to Jun 2026

Segment16 concepts · 147 facts · Dec 2023 to Jun 2026

  • Amortization of intangible assets12 · Dec 2023 to Jun 2026
  • Cost of revenue (US GAAP)12 · Dec 2023 to Jun 2026
  • General and administrative expense (US GAAP)12 · Dec 2023 to Jun 2026
  • Goodwill and intangible asset impairment12 · Dec 2023 to Jun 2026
  • Income tax expense benefit12 · Dec 2023 to Jun 2026
  • Net income loss12 · Dec 2023 to Jun 2026
  • Other nonoperating income expense12 · Dec 2023 to Jun 2026
  • Research and development expense12 · Dec 2023 to Jun 2026
  • Revenue12 · Dec 2023 to Jun 2026
  • Selling and marketing expense (US GAAP)12 · Dec 2023 to Jun 2026
  • Business combination contingent consideration arrangements change in amount of contingent consideration liability110 · Dec 2023 to Jun 2026
  • Gain loss on disposition of assets14 · Mar 2025 to Jun 2026
  • Settlement charges4 · Mar 2025 to Jun 2026
  • Business combination acquisition related costs3 · Dec 2023 to Dec 2025
  • Gains losses on extinguishment of debt3 · Dec 2023 to Dec 2025
  • Gains losses on restructuring of debt3 · Dec 2023 to Dec 2025

Product3 concepts · 78 facts · Dec 2023 to Jun 2026

  • Revenue48 · Dec 2023 to Jun 2026
  • Cost of goods and service excluding depreciation depletion and amortization24 · Dec 2023 to Jun 2026
  • Contract with customer liability revenue recognized6 · Jun 2025 to Jun 2026

Geography1 concepts · 39 facts · Dec 2023 to Jun 2026

  • Revenue39 · Dec 2023 to Jun 2026

Segments

264 facts

Figures broken down by business line, region, product or another axis the company reports on.

Statement business segments1 member · 147 facts

  • Reportable147 · Dec 2023 to Jun 2026

Product or service5 members · 78 facts

  • Product24 · Dec 2023 to Jun 2026
  • Service And Other24 · Dec 2023 to Jun 2026
  • Consumable12 · Dec 2023 to Jun 2026
  • Instrument12 · Dec 2023 to Jun 2026
  • Service6 · Jun 2025 to Jun 2026

Statement geographical4 members · 39 facts

  • Americas12 · Dec 2023 to Jun 2026
  • Asia Pacific12 · Dec 2023 to Jun 2026
  • EMEA12 · Dec 2023 to Jun 2026
  • US3 · Dec 2023 to Dec 2025

Text from filings

Management commentary and risk factors, extracted from SEC filings only.

No commentary or risk-factor text for this company.

Earnings calls

4 calls · Nov 2025 to Aug 2026

Transcripts with management claims and analyst questions, one per fiscal period.

  • FY2026 Q2Aug 5, 2026
  • FY2026 Q1May 8, 2026
  • FY2025 Q4Feb 12, 2026
  • FY2025 Q3Nov 5, 2025

Executive media

Podcasts, interviews and conference appearances by the company's executives, with their claims.

No media appearances for this company.

Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 16, 2026) and refreshed every few hours.

Pacific Biosciences of California Inc. Common Stock (PACB) data · FactIQ